EUVIMEDEUVIMED entdecken
Crossref

CRISPR-BASED NOVEL THERAPEUTIC STRATEGIES FOR TARGETED CANCER DRUG DEVELOPMENT

International Research Journal of Modernization in Engineering Technology & Science · 09.07.2026

DOI: 10.56726/irjmets101669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Research Journal of Modernization in Engineering Technology & Science, online erschienen am 09.07.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of CRISPR-Cas9 technology has revolutionized the field of cancer therapeutics by enabling precise, efficient, and programmable genome editing.This advanced system offers unprecedented opportunities for the development of targeted cancer treatments by directly modifying oncogenes, tumor suppressor genes, and regulatory elements involved in tumor progression.The present study explores CRISPRbased novel therapeutic strategies for targeted cancer drug development, focusing on its application in gene knockout, gene correction, and epigenetic modulation.By selectively disrupting cancer-driving mutations or restoring normal gene function, CRISPR technology enhances treatment specificity while minimizing off-target effects and systemic toxicity.CRISPR is being integrated with innovative drug delivery systems, including viral vectors and non-viral nanocarriers, to improve cellular uptake and therapeutic efficiency.The approach also facilitates the identification and validation of new molecular targets through functional genomic screening, thereby accelerating anticancer drug discovery.Despite its promising potential, challenges such as off-target editing, immune responses, and delivery limitations remain critical concerns that require further optimization.Advances in high-fidelity Cas variants and targeted delivery platforms are expected to overcome these barriers.CRISPR-based therapeutic strategies represent a transformative paradigm in precision oncology, offering highly specific and personalized treatment options.Continued research and technological refinement will be essential to translate these innovations from experimental models to clinical applications, ultimately improving outcomes for cancer patients.

Zitieren

APA

(2026). CRISPR-BASED NOVEL THERAPEUTIC STRATEGIES FOR TARGETED CANCER DRUG DEVELOPMENT. International Research Journal of Modernization in Engineering Technology & Science. https://doi.org/10.56726/irjmets101669

Vancouver

CRISPR-BASED NOVEL THERAPEUTIC STRATEGIES FOR TARGETED CANCER DRUG DEVELOPMENT. International Research Journal of Modernization in Engineering Technology & Science. 2026. doi:10.56726/irjmets101669

BibTeX
@article{euvimed2026,
  title = {CRISPR-BASED NOVEL THERAPEUTIC STRATEGIES FOR TARGETED CANCER DRUG DEVELOPMENT},
  journal = {International Research Journal of Modernization in Engineering Technology & Science},
  year = {2026},
  doi = {10.56726/irjmets101669}
}
Kostenlos starten →